Vaccines - Global Market Outlook (2018-2027)

1 Executive Summary      
        
2 Preface       
 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis     
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 Technology Analysis    
 3.7 End User Analysis     
 3.8 Emerging Markets     
 3.9 Impact of Covid-19    
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Vaccines Market, By Type    
 5.1 Introduction     
 5.2 Multivalent Vaccines    
 5.3 Monovalent Vaccines    
        
6 Global Vaccines Market, By Technology    
 6.1 Introduction     
 6.2 Conjugate Vaccines         
 6.3 Recombinant Vaccines        
 6.4 Toxoid Vaccines          
 6.5 Polysaccharide Vaccines         
 6.6 Inactivated & Subunit Vaccines       
 6.7 Live Attenuated Vaccines         
 6.8 Viral Vaccines          
        
7 Global Vaccines Market, By Distribution Channel   
 7.1 Introduction     
 7.2 Government Suppliers    
 7.3 Hospital & Retial Pharmacies    
        
8 Global Vaccines Market, By Route of Administration  
 8.1 Introduction     
 8.2 Intradermal          
 8.3 Intramuscular and Subcutaneous Administration  
 8.4 Oral Administration     
 8.5 Other Routes of Administration   
  8.5.1 Transcutaneous (TC)   
  8.5.2 Nasal Route    
        
9 Global Vaccines Market, By Disease Indication   
 9.1 Introduction     
 9.2 Cancer           
 9.3 Cholera           
 9.4 Dengue           
 9.5 Diphtheria, Pertussis, and Tetanus (DTP)      
 9.6 Hepatitis           
 9.7 Herpes Zoster          
 9.8 Human Papilloma Virus (HPV)        
 9.9 Influenza           
 9.10 Measles, Mumps, and Rubella (MMR)       
 9.11 Meningococcal Disease         
 9.12 Pneumococcal Disease        
 9.13 Polio             
 9.14 Rabies            
 9.15 Rotavirus           
 9.16 Typhoid Fever          
 9.17 Varicella            
        
10 Global Vaccines Market, By End User    
 10.1 Introduction     
 10.2 Adult Vaccines           
 10.3 Pediatric Vaccines     
 10.4 Traveler Vaccines          
        
11 Global Vaccines Market, By Geography    
 11.1 Introduction     
 11.2 North America     
  11.2.1 US     
  11.2.2 Canada     
  11.2.3 Mexico     
 11.3 Europe      
  11.3.1 Germany     
  11.3.2 UK     
  11.3.3 Italy     
  11.3.4 France     
  11.3.5 Spain     
  11.3.6 Rest of Europe    
 11.4 Asia Pacific     
  11.4.1 Japan     
  11.4.2 China     
  11.4.3 India     
  11.4.4 Australia     
  11.4.5 New Zealand    
  11.4.6 South Korea    
  11.4.7 Rest of Asia Pacific    
 11.5 South America     
  11.5.1 Argentina    
  11.5.2 Brazil     
  11.5.3 Chile     
  11.5.4 Rest of South America   
 11.6 Middle East & Africa    
  11.6.1 Saudi Arabia    
  11.6.2 UAE     
  11.6.3 Qatar     
  11.6.4 South Africa    
  11.6.5 Rest of Middle East & Africa   
        
12 Key Developments      
 12.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 12.2 Acquisitions & Mergers    
 12.3 New Product Launch    
 12.4 Expansions     
 12.5 Other Key Strategies    
        
13 Company Profiling      
 13.1 Johnson & Johnson                  
 13.2 Astrazeneca                     
 13.3 Mitsubishi Tanabe Pharma Corporation              
 13.4 Sanofi Pasteur SA                    
 13.5 CSL Limited                      
 13.6 Emergent Biosolutions Inc                
 13.7 Panacea Biotec LTD                     
 13.8 Bharat Biotech             
 13.9 Serum Institute of India Pvt LTD                 
 13.10 Bavarian Nordic                   
 13.11 Glaxosmithkline PLC        
 13.12 Daiichi Sankyo Company Limited                 
 13.13 Pfizer Inc                    
 13.14 Biological E                      
 13.15 Merck & Co Inc                   

List of Tables       
1 Global Vaccines Market Outlook, By Region (2017-2027) ($MN) 
2 Global Vaccines Market Outlook, By Type (2017-2027) ($MN)  
3 Global Vaccines Market Outlook, By Multivalent Vaccines (2017-2027) ($MN)
4 Global Vaccines Market Outlook, By Monovalent Vaccines (2017-2027) ($MN)
5 Global Vaccines Market Outlook, By Technology (2017-2027) ($MN) 
6 Global Vaccines Market Outlook, By Conjugate Vaccines (2017-2027) ($MN)
7 Global Vaccines Market Outlook, By Recombinant Vaccines (2017-2027) ($MN)
8 Global Vaccines Market Outlook, By Toxoid Vaccines (2017-2027) ($MN) 
9 Global Vaccines Market Outlook, By Polysaccharide Vaccines (2017-2027) ($MN)
10 Global Vaccines Market Outlook, By Inactivated & Subunit Vaccines (2017-2027) ($MN)
11 Global Vaccines Market Outlook, By Live Attenuated Vaccines (2017-2027) ($MN)
12 Global Vaccines Market Outlook, By Viral Vaccines (2017-2027) ($MN) 
13 Global Vaccines Market Outlook, By Distribution Channel (2017-2027) ($MN)
14 Global Vaccines Market Outlook, By Government Suppliers (2017-2027) ($MN)
15 Global Vaccines Market Outlook, By Hospital & Retial Pharmacies (2017-2027) ($MN)
16 Global Vaccines Market Outlook, By Route of Administration (2017-2027) ($MN)
17 Global Vaccines Market Outlook, By Intradermal (2017-2027) ($MN) 
18 Global Vaccines Market Outlook, By Intramuscular and Subcutaneous Administration (2017-2027) ($MN)
19 Global Vaccines Market Outlook, By Oral Administration (2017-2027) ($MN)
20 Global Vaccines Market Outlook, By Other Routes of Administration (2017-2027) ($MN)
21 Global Vaccines Market Outlook, By Transcutaneous (TC) (2017-2027) ($MN)
22 Global Vaccines Market Outlook, By Nasal Route (2017-2027) ($MN) 
23 Global Vaccines Market Outlook, By Disease Indication (2017-2027) ($MN)
24 Global Vaccines Market Outlook, By Cancer (2017-2027) ($MN) 
25 Global Vaccines Market Outlook, By Cholera (2017-2027) ($MN) 
26 Global Vaccines Market Outlook, By Dengue (2017-2027) ($MN) 
27 Global Vaccines Market Outlook, By Diphtheria, Pertussis, and Tetanus (DTP) (2017-2027) ($MN)
28 Global Vaccines Market Outlook, By Hepatitis (2017-2027) ($MN) 
29 Global Vaccines Market Outlook, By Herpes Zoster (2017-2027) ($MN) 
30 Global Vaccines Market Outlook, By Human Papilloma Virus (HPV) (2017-2027) ($MN)
31 Global Vaccines Market Outlook, By Influenza (2017-2027) ($MN) 
32 Global Vaccines Market Outlook, By Measles, Mumps, and Rubella (MMR) (2017-2027) ($MN)
33 Global Vaccines Market Outlook, By Meningococcal Disease (2017-2027) ($MN)
34 Global Vaccines Market Outlook, By Pneumococcal Disease (2017-2027) ($MN)
35 Global Vaccines Market Outlook, By Polio (2017-2027) ($MN)  
36 Global Vaccines Market Outlook, By Rabies (2017-2027) ($MN)  
37 Global Vaccines Market Outlook, By Rotavirus (2017-2027) ($MN) 
38 Global Vaccines Market Outlook, By Typhoid Fever (2017-2027) ($MN) 
39 Global Vaccines Market Outlook, By Varicella (2017-2027) ($MN) 
40 Global Vaccines Market Outlook, By End User (2017-2027) ($MN) 
41 Global Vaccines Market Outlook, By Adult Vaccines (2017-2027) ($MN) 
42 Global Vaccines Market Outlook, By Pediatric Vaccines(2017-2027) ($MN)
43 Global Vaccines Market Outlook, By Traveler Vaccines (2017-2027) ($MN)
        
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.